Citation Impact
Citing Papers
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
‘Green revolution’ genes encode mutant gibberellin response modulators
1999 StandoutNature
HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women
1997
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
1991
The sequence of the gene encoding elongation factor Tu from Chlamydia trachomatis compared with those of other organisms
1992
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Risk factors for osteoporosis
1992
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Interventions for enhancing medication adherence
2005
Effects of a new estrogen/progestin combination in the treatment of postmenopausal syndrome
1995
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Endometriosis
2009 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials
1997
The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin–angiotensin system in normotensive postmenopausal women
1999
Vitamin D Deficiency
2007 Standout
Prediction of fracture from low bone mineral density measurements overestimates risk
2000
PATHOPHYSIOLOGY OF OSTEOPOROSIS
1998
Net Fluxes Over Working Thigh of Hormones, Growth Factors and Biomarkers of Bone Metabolism During Short Lasting Dynamic Exercise
1997
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1992
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Differing Responses in Blood Pressure Over 24 Hours in Normotensive Women Receiving Oral or Transdermal Estrogen Replacement Therapy
1997
A Novel Interaction between Adrenergic Receptors and the α-Subunit of Eukaryotic Initiation Factor 2B
1997 StandoutNobel
17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium.
1994
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Translation in plants-rules and exceptions
1996
A family history of fracture and fracture risk: a meta-analysis
2004
DMC1: A meiosis-specific yeast homolog of E. coli recA required for recombination, synaptonemal complex formation, and cell cycle progression
1992
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
1998
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden
2000
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
2002
Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women
1995
Renin angiotensin system and gender differences in the cardiovascular system
2002
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Effects of conjugated oestrogen and droloxifene on the renin–angiotensin system, blood pressure and renal blood flow in postmenopausal women
2004
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis
1992
Endometriosis
2010 Standout
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
THE PATHOPHYSIOLOGY AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
1997
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Outcome variables in osteoporosis trials
1992
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Ultraviolet radiation and autoimmune disease: insights from epidemiological research
2002
Estrogen, natriuretic peptides and the renin–angiotensin system
1999
Do Markers of Bone Resorption Add to Bone Mineral Density and Ultrasonographic Heel Measurement for the Prediction of Hip Fracture in Elderly Women? The EPIDOS Prospective Study
1998
Production and Actions of Estrogens
2002 Standout
Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels
2012 Standout
Evaluation of the risk of hip fracture
1996
Programmed Cell Death in Animal Development
1997 Standout
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Biochemical Markers of Bone Metabolism: An Overview
1997
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
2000 StandoutNature
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Efficacy and Safety of Oral Weekly Ibandronate in the Treatment of Postmenopausal Osteoporosis
2003
Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.
1992
Translocation of RNA Granules in Living Neurons
1996
Relationship of Bone Turnover to Bone Density and Fractures
1997
Translation elongation factor Tu cleaved by a phage-exclusion system.
1994
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective
2008
Mechanism and regulation of eukaryotic protein synthesis
1992
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Estradiol Induces Discordant Angiotensin and Blood Pressure Responses to Orthostasis in Healthy Postmenopausal Women
2005
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Structural basis for mRNA surveillance by archaeal Pelota and GTP-bound EF1α complex
2010
Bone Resorption by Osteoclasts
2000 StandoutScience
Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women
1999
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
1996
Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts
2001
A Plastid of Probable Green Algal Origin in Apicomplexan Parasites
1997 StandoutScience
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Structural Relationship of Bacterial RecA Proteins to Recombination Proteins from Bacteriophage T4 and Yeast
1993 StandoutScienceNobel
Generation and reproductive phenotypes of mice lacking estrogen receptor β
1998 StandoutNobel
Interventions for enhancing medication adherence
2008 Standout
From Density to Structure: Growing Up and Growing Old on the Surfaces of Bone
1997
Mild versus definite osteoporosis: Comparison of bone densitometry techniques using different statistical models
1989
Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women
1997
Estrogen Modulates AT1Receptor Gene Expression In Vitro and In Vivo
1998
Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study
2000
Two-Year Results of Once-Weekly Administration of Alendronate 70 mg for the Treatment of Postmenopausal Osteoporosis
2002
Molecular cloning and characterization of cDNA encoding the alpha subunit of the rat protein synthesis initiation factor eIF-2B.
1995
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
1992
A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme.
1997 StandoutNobel
Interventions for enhancing medication adherence
2014 Standout
Bone Mass in Prepubertal Children: Gender Differences and the Role of Physical Activity and Sunlight Exposure1
1998
An Unbiased cDNA Library Prepared from IsolatedAplysiaSensory Neuron Processes Is Enriched for Cytoskeletal and Translational mRNAs
2003 StandoutNobel
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
1996
Cryo-EM structure of the mammalian eukaryotic release factor eRF1–eRF3-associated termination complex
2012 StandoutNobel
Type I Collagen Racemization and Isomerization and the Risk of Fracture in Postmenopausal Women: The OFELY Prospective Study
2002
Hormone therapy for endometriosis and surgical menopause
2009
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Estradiol With or Without Progesterone and Ambulatory Blood Pressure in Postmenopausal Women
1999
Apparent Pre- and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort
1997
Identification of many microRNAs that copurify with polyribosomes in mammalian neurons
2003 StandoutNobel
Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D
1995
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Bone metabolism and disease in chronic kidney disease
2003
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Trafficking of Matrix Collagens Through Bone-Resorbing Osteoclasts
1997 Science
Works of B.J. Riis being referenced
Effect of salcatonin given intranasally on early postmenopausal bone loss.
1989
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women
1989
Eukaryotic protein elongation factors
1990
Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women
1988
Precision in assessment of osteoporosis from spine radiographs
1991
Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists?
1990
The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/ progestogen
1989
The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis
1994
Bone mass measured by photon absorptiometry: comparison of forearm, heel, and spine
1990
The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: The effect of nandrolone decanoate and female sex hormones
1991
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study
2009
Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up Study
1996
The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study
1996
Potential risk factors for development of postmenopausal osteoporosis — Examined over a 12-year period
1991
Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy
1995
Desogestrel in hormone replacement therapy: long‐term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding
1991
Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women
1988
CYPROTERONE ACETATE, AN ALTERNATIVE GESTAGEN IN POSTMENOPAUSAL OESTROGEN/GESTAGEN THERAPY
1987
NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS
1989
UNCOUPLING OF BONE FORMATION AND RESORPTION BY COMBINED OESTROGEN AND PROGESTAGEN THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
1985
Immunoassay for quantifying type I collagen degradation products in urine evaluated
1994
Serum concentration of vitamin D metabolites in rheumatoid arthritis
1987
Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium.
1992
PREDICTION OF RAPID BONE LOSS IN POSTMENOPAUSAL WOMEN
1987
The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure.
1987
Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine.
1990
Bone mass, bone structure and vertebral fractures in osteoporotic patients
1987
Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.
1991
Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment.
1995
Evaluation of a new commercial IRMA for bone-specific alkaline phosphatase during treatment with hormone replacement therapy and calcitonin
1996
Ibandronate: A Comparison of Oral Daily Dosing Versus Intermittent Dosing in Postmenopausal Osteoporosis
2001